●February 21, 2012: JKS News: Fuji Seiyaku KK - one of the largest generic makers to start from March 2012 upgrading at the cost of 3.2 billion Yen its manufacturing facility for anti-cancer drugs: first product to be released is a generic version of the antiprostate cancer LH-RH agonist Leuprorelin (leuprolide acetate), which branded version Leuplin marketed by Takeda Yakuhin Kogyo KK will exprire in 2013 ... Product details in JAD Databases

●February 10, 2012: Flu pandemic in Japan (update 17) - preparedness of drugs: Four major pharma makers announced their readiness to supply anti-flu drugs for the current 2011/12 season: Chugai Seiyaku KK - Tamiflu for about 12.4 millions patients; GlaxoSmithKline Japan KK - Relenza for about 8.8 millions patients; Shionogi Seiyaku KK Rapiacta (Peramivir) for about 1 million patients; and Daiichi-Sankyo KK Inavir for about 7 million patients ... Anti-flu products in JAD Databases | Epidemiology consulting and data

●January 3, 2012: JKS News: The Diet passed the fourth supplementary budget with focus on social insurance care ... Japan health insurance consulting | Related report preview

Archived headline news from other periods could be found here:

• News 2006 - 2013

The JAD News Database is currently in beta-testing and expected to be launched in 2011 for all registered users